News from therapeutic solutions international A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Nov 24, 2020, 09:30 ET QuadraMune™ Synergizes with Metformin to Stimulate Anti-Viral Defenses in Pilot Clinical Trial

Therapeutics Solution International, Inc., (OTC Markets: TSOI), reported today clinical trial data demonstrating significant increases in natural...


Nov 16, 2020, 09:30 ET Therapeutic Solutions International Appoints Famela Ramos as Vice President, Business Development

Therapeutics Solution International, Inc., (OTC Markets: TSOI), announced today the appointment of Famela Ramos as the Company's Vice President,...


Nov 10, 2020, 09:35 ET Therapeutic Solutions International Reports Augmentation of Immunotherapy Efficacy in Breast Cancer Model Utilizing Patented NanoStilbene™ Nutraceutical Product

Therapeutics Solution International, Inc., (OTC Markets: TSOI), announced today novel data supporting utilization of the Company's NanoStilbene™...


Oct 29, 2020, 09:30 ET Therapeutic Solutions International Launches Clinical Trial to Validate First Blood Based Predicator of Suicidal Ideation: The Campbell Score™

Therapeutics Solution International, Inc., (OTC Markets: TSOI), announced today publication on the NIH clinical trials website1 of its newly...


Oct 28, 2020, 10:38 ET JadiCell™ Stem Cells Licensed by Therapeutic Solutions International for Brain Injury Significantly Increased Survival of COVID-19 Patients in Double Blind FDA Clinical Trial

Therapeutics Solution International, Inc., (OTC Markets: TSOI), reported today a publication from the University of Miami1, demonstrating intravenous ...


Oct 27, 2020, 09:45 ET Therapeutic Solutions International Identifies New Mechanism of Mesenchymal Stem Cell Treatment of Brain Injury

Therapeutics Solution International, Inc., (OTC Markets: TSOI), announced today filing of a patent application covering novel findings demonstrating...


Oct 12, 2020, 10:07 ET Therapeutic Solutions International Appoints Serena Robella as Director of Sales

Therapeutics Solution International, Inc., (OTC Markets: TSOI), announced today the appointment of Serena Robella as Director of Sales. Ms. Robella...


Oct 05, 2020, 09:35 ET Therapeutic Solutions International announced today appointment of J Christopher Mizer to the Advisory Board of its Campbell Neurosciences Division

Therapeutics Solution International, Inc., (OTC Markets: TSOI), announced today the appointment of J Christopher Mizer to the Advisory Board of its...


Sep 28, 2020, 09:30 ET Therapeutic Solutions International Reports Positive Preclinical Data on JadiCell™ Universal Donor Stem Cell Therapy for Brain Injury

Therapeutics Solutions International, Inc., (OTC Markets: TSOI), reported today positive preclinical data demonstrating superior neuro-regenerative...


Sep 24, 2020, 09:35 ET Therapeutic Solutions International Announces Proof of Concept Data and Patent Filing for Neuroleukin™: The First Immune Based Suicide Prevention Biological Therapy

Therapeutics Solution International, Inc., (OTC Markets: TSOI), announced today the launch of Neuroleukin™, a personalized biological product...


Sep 14, 2020, 09:35 ET Therapeutic Solutions International Files Comprehensive Campbell Platform™ Patent for Stem Cell Immunotherapy of Schizophrenia

Therapeutics Solution International, Inc., (OTC Markets: TSOI), announced today filing of a landmark patent, with over 1000 claims, covering stem...


Aug 28, 2020, 09:30 ET Therapeutic Solutions International Reports Synergistic Suppression of Suicide-Associated Neuroinflammatory Pathway by QuadraMune™ and Minocycline

Therapeutics Solution International, Inc., (OTC Markets: TSOI), reported filing a patent on new data showing synergy between QuadraMune™ and...


Aug 05, 2020, 09:40 ET Therapeutic Solutions International Reports Reduction of Inflammation Associated Memory Impairment by QuadraMune™ Administration

Therapeutics Solution International, Inc., (OTC Markets: TSOI), announced today filing of a patent on new data demonstrating memory-protective...


Jul 28, 2020, 09:45 ET Therapeutic Solutions International Files Patent on Ability of QuadraMune Ingredient Pterostilbene to Reduce Inflammation while Stimulating Brain Protective Biological Pathways

Therapeutics Solution International, Inc., (OTC Markets: TSOI), reported new data demonstrating that the blueberry derived compound pterostilbene...


Jul 07, 2020, 09:00 ET Therapeutic Solutions International Submits Publication on StemVacs™ Preclinical Data Supporting COVID-19 Indication

Therapeutic Solutions International, Inc., (OTC Markets: TSOI), announced submission of a publication providing preclinical data which supports...